查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1606473

基于人工智慧的疾病诊断市场，按组件类型、诊断类型和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

AI-based Disease Diagnosis Market, By Component Type, By Diagnosis Type, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 260 Pages | 商品交期: 2-3个工作天内

价格
简介目录

报告要点

基于人工智慧的疾病诊断市场预计到 2023 年将达到 13.545 亿美元，2024 年至 2032 年复合年增长率为 24.20%。

此外，疾病检测中的人工智慧可以支援个人化治疗，这在世界医疗保健系统中迅速普及。预计在预测期内，对传统医疗基础设施不断增长的需求将为基于人工智慧的疾病诊断市场带来显着的成长动力。然而，创建和实施该技术的高成本可能会影响市场成长率。

基于人工智慧的疾病诊断市场-市场动态

全球患者数量不断增加，医疗基础设施不断恶化

全球患者数量的不断增长预计将推动基于人工智慧的疾病诊断市场的成长。需要医疗照护的人数不断增加，给目前的医疗保健系统带来了巨大压力。由于缺乏诊断中心、医疗保健从业人员和设施以及医疗保健成本不断上涨，许多人无法获得高品质的医疗。据市场调查显示，非洲每万人就有一名医生。已开发国家以及世界其他地区也有类似的数字。此外，2019 年世界经济论坛的一项研究称，富裕国家医疗保健品质不佳，每年导致超过 600 万人死亡。此外，患者数逐年增加。患者数量的增加归因于抗药性菌株的出现、人口老化以及自体免疫疾病患者数量的增加。透过利用人工智慧进行疾病诊断，现有的医疗保健系统可以更好地满足患者不断变化的要求和需求。

基于人工智慧的疾病诊断市场-关键见解

根据我们的研究分析师的分析，预计在 2024 年至 2032 年的预测期内，全球市场将以约 24.20% 的复合年增长率扩张。

根据组件类型，预计软体类别将在 2023 年占据最大的市场份额。

根据诊断类型，预计放射学类别将在 2023 年占据最大的市场份额。

2023 年，按地区划分，北美地区的收入份额最大。

基于人工智慧的疾病诊断市场-細項分析：

全球基于人工智慧的疾病诊断市场分为组件类型、诊断类型和区域。

根据组件类型，市场分为三个部分：软体、服务和硬体。 2023 年，软体领域带来的收入最多。人工智慧诊断的主要组成部分是整合到软体平台中的复杂演算法和机器学习模型。软体是人工智慧驱动诊断的基础，因为这些平台可以评估复杂的医疗资料（包括成像和基因组资料），并提供有用的见解。医疗保健从业者可以透过不断更新和改进具有新功能、演算法和功能的软体来维持诊断技术的前沿。人工智慧诊断的快速发展使得这种灵活性和可扩展性变得至关重要。

就诊断类型而言，市场分为心臟病学、肿瘤学、放射学、胸肺学、神经学、病理学等。 2023 年，就收入份额而言，市场领导者是放射科。放射学研究需要分析大量来自 CT、MRI、超音波和 X 光的医学图片。由于人工智慧工具非常擅长处理和解读这些影像，因此放射学是整合人工智慧的好地方。人工智慧快速且精准的影像分析大大提高了诊断效率并引发了广泛应用。最早使用人工智慧的医学专业之一是放射学，即影像解释和识别。自从人工智慧首次应用于放射学以来，更复杂、更先进的人工智慧技术已经被开发出来。它们现在在医疗机构中广泛使用和信任，这有助于该行业的蓬勃发展。

基于AI的疾病诊断市场-地理洞察

基于人工智慧的疾病诊断市场广泛分布于北美、拉丁美洲、欧洲、亚太、中东和非洲。这些区域根据提供业务的国家进一步划分。

2023年，北美在基于人工智慧的疾病诊断领域引领全球市场。在使用新技术进行患者治疗和疾病诊断方面，美国处于领先地位。此外，开发识别人工智慧技术与临床护理环境中实际实施之间任何不一致的能力将是工作的重点。患者和医疗专业人员都将从这些改进中受益。

基于人工智慧的疾病诊断市场预计亚太地区将成为第二大收入来源。由于当地医疗机构、投资和人工智慧技术发展的压力日益加大，该地区的人口数量将会增加。内视镜顶级製造商之一奥林巴斯于2024年7月表示，将利用AI进军诊断平台市场。透过使用将平台连接到医院内视镜的云端服务，该试点计画将在亚太地区推出。

基于人工智慧的疾病诊断市场-竞争格局：

基于AI的疾病诊断市场存在Babylon Health、Tempus、Arterys、IBM Watson Health、Insilico Medicine、Zebra Medical Vision等几大主要竞争对手，技术创新和策略联盟是重点。企业正在花钱购买由人工智慧支援的分析平台，这些平台可以提供有关患者结果和疾病趋势的更深入的知识。为了提供更准确、更快速、更精确的结果，人们也越来越重视将人工智慧与当前基础设施和医学影像功能结合。此外，数位公司和医疗保健提供者之间的合作不断增长，刺激了创新并扩大了人工智慧工具和解决方案在一系列医疗保健领域的使用。

最新进展：

2024 年 6 月：Aidoc 刚刚发布了新的人工智慧患者管理系统，该系统提高了诊所的吞吐量并改善了患者护理。预计此次推出将提高公司在市场中的地位并扩大其客户群。

2024年6月：AliveCor宣布Kardia 12L心电图系统及其KAI 12L人工智慧技术已获得FDA批准并将开始销售。由于此次批准，预计该公司的销售前景在不久的将来将会改善。

2024 年 4 月：MindSculpt Analytics 和 Happiest Mind Technologies Limited 宣布合作。新的合作伙伴关係重点关注个人健康和保健，旨在利用人工智慧和机器学习技术提供尖端的医疗诊断解决方案。

目录

第一章：基于人工智慧的疾病诊断市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 基于人工智慧的疾病诊断市场片段（按组件类型）
    • 基于人工智慧的疾病诊断市场片段（按诊断类型）
    • 基于人工智慧的疾病诊断市场片段（按国家/地区）
    • 基于人工智慧的疾病诊断市场片段（按地区）
  • 竞争洞察

第 3 章：基于人工智慧的疾病诊断主要市场趋势

  • 基于人工智慧的疾病诊断市场驱动因素
    • 市场驱动因素的影响分析
  • 基于人工智慧的疾病诊断市场限制
    • 市场限制影响分析
  • 基于人工智慧的疾病诊断市场机会
  • 基于人工智慧的疾病诊断市场未来趋势

第四章：人工智慧疾病诊断产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：基于人工智慧的疾病诊断市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：基于人工智慧的疾病诊断市场格局

  • 2023年基于人工智慧的疾病诊断市占分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：基于人工智慧的疾病诊断市场 - 按组件类型

  • 概述
    • 按组件类型分類的细分市场份额分析
    • 软体
    • 服务
    • 硬体

第 8 章：基于人工智慧的疾病诊断市场 - 按诊断类型

  • 概述
    • 按诊断类型分類的细分市场份额分析
    • 心臟病学
    • 肿瘤学
    • 放射科
    • 胸肺
    • 神经病学
    • 病理
    • 其他的

第 9 章：基于人工智慧的疾病诊断市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 基于人工智慧的疾病诊断北美主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按组件类型）
    • 北美市场规模和预测（按诊断类型）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲基于人工智慧的疾病诊断主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模和预测（按组件类型）
    • 欧洲市场规模和预测（按诊断类型）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区基于人工智慧的疾病诊断主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模和预测（按组件类型）
    • 亚太地区市场规模和预测（按诊断类型）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲基于人工智慧的疾病诊断主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模和预测（按组件类型）
    • 拉丁美洲市场规模和预测（按诊断类型）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 基于人工智慧的疾病诊断中东和非洲主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按组件类型）
    • 中东和非洲市场规模及预测（按诊断类型）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第10章：主要供应商分析-基于人工智慧的疾病诊断产业

  • 竞争仪表板
  • 公司简介
    • Babylon Health
    • Tempus
    • Arterys
    • IBM Watson Health
    • Insilico Medicine
    • Zebra Medical Vision
    • PathAI
    • Buoy Health
    • Freenome
    • Lunit
    • Viz.ai
    • Aidoc
    • Butterfly Network
    • CureMetrix
    • Qure.ai.
    • Others

第 11 章：360 度分析师视角

第 12 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV4269

REPORT HIGHLIGHT

The market for AI-based Disease Diagnosis was projected to reach USD 1,354.5 million in 2023 and expand at a CAGR of 24.20% between 2024 - 2032.

The employment of artificial intelligence (AI) technology in the healthcare sector during the disease diagnosis stage is known as AI-based disease diagnosis. Demand for and investment in AI in healthcare has been rising quickly across all industries. The trend is fueled by a number of benefits that AI technology provides. Recently, artificial intelligence has drawn interest from all across the world. In order to duplicate human intelligence, the technology makes use of a number of cutting-edge technologies. Medical picture analysis, disease prediction, and condition detection are just a few of the advanced jobs that AI allows machines to accomplish.

Additionally, AI in disease detection can support individualized treatment, which is rapidly gaining popularity in the world's healthcare system. The growing demand for conventional healthcare infrastructure is anticipated to generate significant growth momentum for the AI-based disease diagnosis market during the projected period. However, the high cost of creating and implementing the technology may affect the rate of market growth.

AI-based Disease Diagnosis Market- Market Dynamics

Growing Number of Patients Worldwide, as well as the Deteriorating Healthcare Infrastructure

The growing number of patients worldwide is anticipated to fuel growth in the market for AI-based disease diagnostics. The growing number of people in need of medical care is putting a great deal of strain on the current healthcare system. Many people lack access to high-quality medical treatment as a result of the absence of diagnostic centers, healthcare practitioners, and facilities, as well as the rising cost of healthcare. According to a market survey, there is one doctor for every 10,000 people in Africa. Developed countries, as well as other parts of the world, have similar figures. Moreover, a 2019 World Economic Forum research claims that the inadequate quality of healthcare in wealthy countries causes over 6 million deaths annually. In addition, the number of patients has been increasing annually. The rise in the number of patients is ascribed to the development of drug-resistant disease strains, the aging of the population, and the growing number of autoimmune disease patients. The existing healthcare system can better meet the evolving requirements and demands of patients by utilizing artificial intelligence in disease diagnostics.

AI-based Disease Diagnosis Market- Key Insights

According to our research analyst's analysis, the global market is projected to expand at a CAGR of approximately 24.20% during the forecast period of 2024-2032.

The software category was predicted to hold the largest market share in 2023 based on component type.

The radiology category was predicted to hold the largest market share in 2023 based on diagnosis type.

North America held the largest revenue share by region in 2023.

AI-based Disease Diagnosis Market- Segmentation Analysis:

The Global AI-based Disease Diagnosis Market is segmented into Component Type, Diagnosis Type, and Region.

The market is divided into three segments based on the component type: software, services, and hardware. In 2023, the software segment brought in the most money. The main components of AI diagnostics are complex algorithms and machine learning models that are integrated into software platforms. Software is the foundation of AI-driven diagnostics since these platforms evaluate intricate medical data, including imaging and genomic data, and offer useful insights. Healthcare practitioners can stay on the cutting edge of diagnostic technology by continually updating and improving software with new features, algorithms, and capabilities. The quick development of AI diagnostics has made this flexibility and scalability essential.

In terms of diagnosis type, the market is segmented into Cardiology, Oncology, Radiology, Chest & Lung, Neurology, Pathology, and Others. In 2023, the market leader in terms of revenue share was the radiology segment. The study of radiology entails analyzing vast amounts of medical pictures from CT, MRI, ultrasound, and X-rays. Because AI tools are so good at processing and deciphering these images, radiology is a great place to integrate AI. AI's rapid and precise picture analysis has greatly increased diagnostic effectiveness and sparked widespread use. One of the first medical specialties to use AI was radiology, namely in picture interpretation and recognition. Since AI was first used in radiology, more sophisticated and advanced AI technologies have been developed. They are now extensively used and trusted in healthcare institutions, which has helped the industry flourish.

AI-based Disease Diagnosis Market- Geographical Insights

The AI-based Disease Diagnosis market is widely distributed geographically in North America, Latin America, Europe, Asia Pacific, the Middle East and Africa. These areas are further separated based on the countries that provide business.

North America led the global market for AI-based disease diagnosis in 2023. Due in large part to its highly developed and technologically advanced health infrastructure, the United States is the most powerful country in North America. When it comes to using new technologies for patient treatment and disease diagnosis, the US has led the way. Additionally, developing the ability to identify any misalignment between AI-enabled technologies and practical implementations in the clinical care setting will be the focus of the efforts. Patients as well as medical professionals, will benefit from these improvements.

The AI-based disease diagnosis market is expected to see Asia-Pacific become the second-largest revenue generator. The region will increase as a result of the increasing strain on local healthcare organizations, investments, and developments in AI technology. One of the top manufacturers of endoscopes, Olympus, said in July 2024 that it will use AI to enter the diagnostic platform market. With the use of a cloud-based service that links the platform to hospital endoscopes, the pilot project will be introduced in Asia Pacific.

AI-based Disease Diagnosis Market- Competitive Landscape:

Several major competitors, such as Babylon Health, Tempus, Arterys, IBM Watson Health, Insilico Medicine, and Zebra Medical Vision, among others, are present in the AI-based disease diagnosis market, and technological innovation and strategic alliances are prioritized. Businesses are spending money on analytics platforms powered by AI that offer more in-depth knowledge about patient outcomes and illness trends. In order to provide more accurate, quick, and exact results, there is also an increasing emphasis on integrating AI with current infrastructure and medical imaging capabilities. Additionally, collaborations between digital companies and healthcare providers are growing, spurring innovation and broadening the use of AI tools and solutions in a range of healthcare fields.

Recent Developments:

June 2024: The new AI-powered patient management system from Aidoc, which increases clinic throughput and advances patient care, was just released. It is anticipated that this launch will improve the company's standing in the marketplace and allow it to grow its clientele.

June 2024: AliveCor declared that the Kardia 12L ECG System and its KAI 12L AI technology had received FDA approval and would be going on sale. The company's sales prospects are anticipated to improve in the near future as a result of this approval.

April 2024: MindSculpt Analytics and Happiest Mind Technologies Limited announced their collaboration. With an emphasis on personal health and wellness, the new partnership seeks to provide cutting-edge medical diagnostic solutions by utilizing artificial intelligence and machine learning technology.

SCOPE OF THE REPORT

The scope of this report covers the AI-based Disease Diagnosis market by its major segments, which include as follows:

GLOBAL AI-BASED DISEASE DIAGNOSIS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Babylon Health
  • Tempus
  • Arterys
  • IBM Watson Health
  • Insilico Medicine
  • Zebra Medical Vision
  • PathAI
  • Buoy Health
  • Freenome
  • Lunit
  • Viz.ai
  • Aidoc
  • Butterfly Network
  • CureMetrix
  • Qure.ai.
  • Others

GLOBAL AI-BASED DISEASE DIAGNOSIS MARKET, BY COMPONENT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Software
  • Services
  • Hardware

GLOBAL AI-BASED DISEASE DIAGNOSIS MARKET, BY DIAGNOSIS TYPE- MARKET ANALYSIS, 2019 - 2032

  • Cardiology
  • Oncology
  • Radiology
  • Chest & Lung
  • Neurology
  • Pathology
  • Others

GLOBAL AI-BASED DISEASE DIAGNOSIS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. AI-based Disease Diagnosis Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. AI-based Disease Diagnosis Market Snippet by Component Type
    • 2.1.2. AI-based Disease Diagnosis Market Snippet by Diagnosis Type
    • 2.1.3. AI-based Disease Diagnosis Market Snippet by Country
    • 2.1.4. AI-based Disease Diagnosis Market Snippet by Region
  • 2.2. Competitive Insights

3. AI-based Disease Diagnosis Key Market Trends

  • 3.1. AI-based Disease Diagnosis Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. AI-based Disease Diagnosis Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. AI-based Disease Diagnosis Market Opportunities
  • 3.4. AI-based Disease Diagnosis Market Future Trends

4. AI-based Disease Diagnosis Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. AI-based Disease Diagnosis Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. AI-based Disease Diagnosis Market Landscape

  • 6.1. AI-based Disease Diagnosis Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. AI-based Disease Diagnosis Market - By Component Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Component Type, 2023 & 2032 (%)
    • 7.1.2. Software
    • 7.1.3. Services
    • 7.1.4. Hardware

8. AI-based Disease Diagnosis Market - By Diagnosis Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Diagnosis Type, 2023 & 2032 (%)
    • 8.1.2. Cardiology
    • 8.1.3. Oncology
    • 8.1.4. Radiology
    • 8.1.5. Chest & Lung
    • 8.1.6. Neurology
    • 8.1.7. Pathology
    • 8.1.8. Others

9. AI-based Disease Diagnosis Market- By Geography

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. AI-based Disease Diagnosis Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
    • 9.2.6. U.S.
      • 9.2.6.1. Overview
      • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.6.3. U.S. Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 9.2.6.4. U.S. Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
    • 9.2.7. Canada
      • 9.2.7.1. Overview
      • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.7.3. Canada Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 9.2.7.4. Canada Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. AI-based Disease Diagnosis Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
    • 9.3.6. Germany
      • 9.3.6.1. Overview
      • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.6.3. Germany Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 9.3.6.4. Germany Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
    • 9.3.7. Italy
      • 9.3.7.1. Overview
      • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.7.3. Italy Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 9.3.7.4. Italy Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
    • 9.3.8. United Kingdom
      • 9.3.8.1. Overview
      • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.8.3. United Kingdom Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 9.3.8.4. United Kingdom Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
    • 9.3.9. France
      • 9.3.9.1. Overview
      • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.9.3. France Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 9.3.9.4. France Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
    • 9.3.10. Russia
      • 9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.10.2. Russia Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 9.3.10.3. Russia Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
    • 9.3.11. Netherlands
      • 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.11.2. Netherlands Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 9.3.11.3. Netherlands Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
    • 9.3.12. Sweden
      • 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.12.2. Sweden Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 9.3.12.3. Sweden Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
    • 9.3.13. Poland
      • 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.13.2. Poland Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 9.3.13.3. Poland Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
    • 9.3.14. Rest of Europe
      • 9.3.14.1. Overview
      • 9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.14.3. Rest of the Europe Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 9.3.14.4. Rest of the Europe Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. AI-based Disease Diagnosis Key Manufacturers in Asia Pacific
    • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.4.4. Asia Pacific Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
    • 9.4.5. Asia Pacific Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
    • 9.4.6. India
      • 9.4.6.1. Overview
      • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.6.3. India Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 9.4.6.4. India Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
    • 9.4.7. China
      • 9.4.7.1. Overview
      • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.7.3. China Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 9.4.7.4. China Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
    • 9.4.8. Japan
      • 9.4.8.1. Overview
      • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.8.3. Japan Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 9.4.8.4. Japan Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
    • 9.4.9. South Korea
      • 9.4.9.1. Overview
      • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.9.3. South Korea Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 9.4.9.4. South Korea Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
    • 9.4.10. Australia
      • 9.4.10.1. Overview
      • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.10.3. Australia Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 9.4.10.4. Australia Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
    • 9.4.11. Thailand
      • 9.4.11.1. Overview
      • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.11.3. Thailand Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 9.4.11.4. Thailand Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
    • 9.4.12. Indonesia
      • 9.4.12.1. Overview
      • 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.12.3. Indonesia Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 9.4.12.4. Indonesia Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
    • 9.4.13. Philippines
      • 9.4.13.1. Overview
      • 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.13.3. Philippines Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 9.4.13.4. Philippines Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
    • 9.4.14. Rest of APAC
      • 9.4.14.1. Overview
      • 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.14.3. Rest of APAC Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 9.4.14.4. Rest of APAC Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
  • 9.5. Latin America
    • 9.5.1. Overview
    • 9.5.2. AI-based Disease Diagnosis Key Manufacturers in Latin America
    • 9.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.5.4. Latin America Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
    • 9.5.5. Latin America Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
    • 9.5.6. Brazil
      • 9.5.6.1. Overview
      • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.6.3. Brazil Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 9.5.6.4. Brazil Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
    • 9.5.7. Mexico
      • 9.5.7.1. Overview
      • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.7.3. Mexico Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 9.5.7.4. Mexico Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
    • 9.5.8. Argentina
      • 9.5.8.1. Overview
      • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.8.3. Argentina Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 9.5.8.4. Argentina Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
    • 9.5.9. Colombia
      • 9.5.9.1. Overview
      • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.9.3. Colombia Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 9.5.9.4. Colombia Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
    • 9.5.10. Rest of LATAM
      • 9.5.10.1. Overview
      • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.10.3. Rest of LATAM Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 9.5.10.4. Rest of LATAM Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Overview
    • 9.6.2. AI-based Disease Diagnosis Key Manufacturers in Middle East and Africa
    • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.6.4. Middle East and Africa Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
    • 9.6.5. Middle East and Africa Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
    • 9.6.6. Saudi Arabia
      • 9.6.6.1. Overview
      • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.6.3. Saudi Arabia Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 9.6.6.4. Saudi Arabia Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
    • 9.6.7. United Arab Emirates
      • 9.6.7.1. Overview
      • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.7.3. United Arab Emirates Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 9.6.7.4. United Arab Emirates Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
    • 9.6.8. Israel
      • 9.6.8.1. Overview
      • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.8.3. Israel Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 9.6.8.4. Israel Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
    • 9.6.9. Turkey
      • 9.6.9.1. Overview
      • 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.9.3. Turkey Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 9.6.9.4. Turkey Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
    • 9.6.10. Algeria
      • 9.6.10.1. Overview
      • 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.10.3. Algeria Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 9.6.10.4. Algeria Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
    • 9.6.11. Egypt
      • 9.6.11.1. Overview
      • 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.11.3. Egypt Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 9.6.11.4. Egypt Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)
    • 9.6.12. Rest of MEA
      • 9.6.12.1. Overview
      • 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.12.3. Rest of MEA Market Size and Forecast, By Component Type, 2019 - 2032 (US$ Million)
      • 9.6.12.4. Rest of MEA Market Size and Forecast, By Diagnosis Type, 2019 - 2032 (US$ Million)

10. Key Vendor Analysis- AI-based Disease Diagnosis Industry

  • 10.1. Competitive Dashboard
  • 10.2. Company Profiles
    • 10.2.1. Babylon Health
    • 10.2.2. Tempus
    • 10.2.3. Arterys
    • 10.2.4. IBM Watson Health
    • 10.2.5. Insilico Medicine
    • 10.2.6. Zebra Medical Vision
    • 10.2.7. PathAI
    • 10.2.8. Buoy Health
    • 10.2.9. Freenome
    • 10.2.10. Lunit
    • 10.2.11. Viz.ai
    • 10.2.12. Aidoc
    • 10.2.13. Butterfly Network
    • 10.2.14. CureMetrix
    • 10.2.15. Qure.ai.
    • 10.2.16. Others

11. 360 Degree Analyst View

12. Appendix

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us